These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30085055)

  • 21. Quantitative and qualitative assessment of acute myocardial injury by CMR at multiple time points after acute myocardial infarction.
    Symons R; Claus P; Marchi A; Dresselaers T; Bogaert J
    Int J Cardiol; 2018 May; 259():43-46. PubMed ID: 29506936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of infarct size and myocardium at risk: evaluation of different techniques and its implications.
    McAlindon E; Pufulete M; Lawton C; Angelini GD; Bucciarelli-Ducci C
    Eur Heart J Cardiovasc Imaging; 2015 Jul; 16(7):738-46. PubMed ID: 25736308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial area at risk after ST-elevation myocardial infarction measured with the late gadolinium enhancement after scar remodeling and T2-weighted cardiac magnetic resonance imaging.
    Lønborg J; Engstrøm T; Mathiasen AB; Vejlstrup N
    Int J Cardiovasc Imaging; 2012 Aug; 28(6):1455-64. PubMed ID: 21971845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients.
    Bulluck H; White SK; Rosmini S; Bhuva A; Treibel TA; Fontana M; Abdel-Gadir A; Herrey A; Manisty C; Wan SM; Groves A; Menezes L; Moon JC; Hausenloy DJ
    J Cardiovasc Magn Reson; 2015 Aug; 17(1):73. PubMed ID: 26264813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of semi-automated methods to quantify infarct size and area at risk by cardiovascular magnetic resonance imaging at 1.5T and 3.0T field strengths.
    Khan JN; Nazir SA; Horsfield MA; Singh A; Kanagala P; Greenwood JP; Gershlick AH; McCann GP
    BMC Res Notes; 2015 Feb; 8():52. PubMed ID: 25889795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliability of myocardial salvage assessment by cardiac magnetic resonance imaging in acute reperfused myocardial infarction.
    Desch S; Engelhardt H; Meissner J; Eitel I; Sareban M; Fuernau G; de Waha S; Grothoff M; Gutberlet M; Schuler G; Thiele H
    Int J Cardiovasc Imaging; 2012 Feb; 28(2):263-72. PubMed ID: 21279689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardium at risk by magnetic resonance imaging: head-to-head comparison of T2-weighted imaging and contrast-enhanced steady-state free precession.
    Ubachs JF; Sörensson P; Engblom H; Carlsson M; Jovinge S; Pernow J; Arheden H
    Eur Heart J Cardiovasc Imaging; 2012 Dec; 13(12):1008-15. PubMed ID: 22645203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction.
    Ugander M; Bagi PS; Oki AJ; Chen B; Hsu LY; Aletras AH; Shah S; Greiser A; Kellman P; Arai AE
    JACC Cardiovasc Imaging; 2012 Jun; 5(6):596-603. PubMed ID: 22698528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction.
    Eitel I; Kubusch K; Strohm O; Desch S; Mikami Y; de Waha S; Gutberlet M; Schuler G; Friedrich MG; Thiele H
    Circ Cardiovasc Imaging; 2011 Jul; 4(4):354-62. PubMed ID: 21518773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic performance of dark-blood T2-weighted CMR for evaluation of acute myocardial injury.
    Srichai MB; Lim RP; Lath N; Babb J; Axel L; Kim D
    Invest Radiol; 2013 Jan; 48(1):24-31. PubMed ID: 23192160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac index after acute ST-segment elevation myocardial infarction measured with phase-contrast cardiac magnetic resonance imaging.
    Klug G; Reinstadler SJ; Feistritzer HJ; Kremser C; Schwaiger JP; Reindl M; Mair J; Müller S; Mayr A; Franz WM; Metzler B
    Eur Radiol; 2016 Jul; 26(7):1999-2008. PubMed ID: 26385805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction.
    Eitel I; Desch S; Fuernau G; Hildebrand L; Gutberlet M; Schuler G; Thiele H
    J Am Coll Cardiol; 2010 Jun; 55(22):2470-9. PubMed ID: 20510214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of contemporary electrocardiographic indices of area at risk and infarct size in acute ST elevation myocardial infarction (STEMI).
    Du YT; Pasupathy S; Air T; Neil C; Beltrame JF
    Int J Cardiol; 2020 Mar; 303():1-7. PubMed ID: 31759688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental validation of contrast-enhanced SSFP cine CMR for quantification of myocardium at risk in acute myocardial infarction.
    Nordlund D; Kanski M; Jablonowski R; Koul S; Erlinge D; Carlsson M; Engblom H; Aletras AH; Arheden H
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):12. PubMed ID: 28132648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T2-weighted cardiac MR assessment of the myocardial area-at-risk and salvage area in acute reperfused myocardial infarction: comparison of state-of-the-art dark blood and bright blood T2-weighted sequences.
    Viallon M; Mewton N; Thuny F; Guehring J; O'Donnell T; Stemmer A; Bi X; Rapacchi S; Zuehlsdorff S; Revel D; Croisille P
    J Magn Reson Imaging; 2012 Feb; 35(2):328-39. PubMed ID: 21959873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reproducibility of area at risk assessment in acute myocardial infarction by T1- and T2-mapping sequences in cardiac magnetic resonance imaging in comparison to Tc99m-sestamibi SPECT.
    Langhans B; Nadjiri J; Jähnichen C; Kastrati A; Martinoff S; Hadamitzky M
    Int J Cardiovasc Imaging; 2014 Oct; 30(7):1357-63. PubMed ID: 24984612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of angiographic, electrocardiographic and MRI methods to assess the area at risk in acute myocardial infarction.
    Versteylen MO; Bekkers SC; Smulders MW; Winkens B; Mihl C; Winkens MH; Leiner T; Waltenberger JL; Kim RJ; Gorgels AP
    Heart; 2012 Jan; 98(2):109-15. PubMed ID: 21930725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac MRI: T2-Mapping Versus T2-Weighted Dark-Blood TSE Imaging for Myocardial Edema Visualization in Acute Myocardial Infarction.
    Naßenstein K; Nensa F; Schlosser T; Bruder O; Umutlu L; Lauenstein T; Maderwald S; Ladd ME
    Rofo; 2014 Feb; 186(2):166-72. PubMed ID: 24081784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography.
    Carlsson M; Ubachs JF; Hedström E; Heiberg E; Jovinge S; Arheden H
    JACC Cardiovasc Imaging; 2009 May; 2(5):569-76. PubMed ID: 19442942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.